BioSpace News Archive

Business

Moleculin Reports First Quarter 2023 Financial Results

Moleculin Biotech, Inc. today reported its financial results for the quarter ended March 31, 2023. As previously announced, the Company will host a conference call and live audio webcast, today, Thursday, May 11, 2023, at 8:30 AM ET (details below).

May 11, 2023
·
6 min read
Business

Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023

Bicycle Therapeutics plc (NASDAQ: BCYC) and Orano Med, two biotechnology companies respectively, announce pre-clinical results.

May 11, 2023
·
7 min read
Business

AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update

AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today reported financial results for the first quarter ended March 31, 2023, and provided a business update.

May 11, 2023
·
12 min read
Business

OmniAb Reports First Quarter 2023 Financial Results and Business Highlights

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2023, and provided operating and partner program updates.

May 11, 2023
·
12 min read
Business

Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced financial results for the first quarter ended March 31, 2023 and provided an update on clinical and corporate developments.

May 11, 2023
·
14 min read
Business

Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the first quarter ended March 31, 2023, and provided a clinical and corporate update.

May 11, 2023
·
14 min read
Tesis Biosciences Announces New Test That Can Identify Those in Most Danger from Covid-19

Tesis Biosciences, the leader in targeted genetic sequencing, has developed a new test that identifies the genetic mutations that puts people in the greatest danger from the Covid-19 virus.

May 11, 2023
·
3 min read
Business

Microbix Reports Results for Q2 Fiscal 2023 Sales of $4.2 million and Profitability

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2023 ended March 31, 2023, a period in which a loss was incurred in the first quarter and profitability restored in Q2.

May 11, 2023
·
8 min read
Pharm Country

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China

LianBio announced that CAMZYOS® has received marketing approval for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy from the Pharmaceutical Administration Bureau of the Macau SAR.

May 11, 2023
·
7 min read
BioMidwest

Volition Study shows Nucleosome Concentrations are a useful tool for Canine Cancer Treatment Monitoring

VolitionRx Limited, a multi-national epigenetics company, announces new research - published in PLOS ONE - which reveals that plasma nucleosome concentrations can be a useful tool for treatment monitoring and disease progression in dogs with hematopoietic cancers.

May 11, 2023
·
5 min read